A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone
Status:
Completed
Trial end date:
2016-06-29
Target enrollment:
Participant gender:
Summary
The study is being conducted to assess the effect of multiple doses of BMS-663068 on the
exposure of methadone in subjects on a stable dose of methadone, and the exposure of
buprenorphine and norbuprenorphine in subjects on a stable dose of buprenorphine and
norbuprenorphine.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb ViiV Healthcare
Collaborator:
GlaxoSmithKline
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Fostemsavir Methadone